Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New tool helps nasal cancer patients voice their satisfaction

NCT ID NCT07257094

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study aims to validate a French version of the Nasal Reconstruction FACE-Q questionnaire, which measures how patients feel about their appearance, quality of life, and side effects after nasal reconstruction or prosthetic rehabilitation following nasal skin cancer surgery. About 346 adults who had surgery 4 months to 3 years ago will participate. The goal is to provide a reliable tool for doctors to better understand patient satisfaction and improve care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 346 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients / Controls

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

PATIENTS Inclusion Criteria * Age ≥ 18 years * Patient who has undergone excision of a cutaneous, mucocutaneous, or vestibular nasal cancer with surgical reconstruction using a flap or prosthetic rehabilitation, performed more than 4 months ago, with stable results, and less than 3 years ago * Patient informed of the study and not opposed to participation Exclusion Criteria * Patient under anticoagulant or antiplatelet therapy Non-French-speaking patient * Patient under legal protection (e.g., guardianship, legal safeguard) or with limited legal capacity * Patient unlikely to cooperate with the study and/or poor anticipated compliance as judged by the investigator (including psychiatric disorders other than depressive disorder or cognitive impairment) * Pregnant or breastfeeding woman CONTROL Inclusion Criteria * Age ≥ 65 years * Subject informed and not opposed to participating in the study * Subject who has never undergone facial trauma or surgery, and without major comorbidity, defined as follows: * No heart failure (moderate or severe heart failure, history of heart attack within the last 6 months); * No severe chronic respiratory disease (no stage III-IV COPD, no prolonged oxygen therapy); * No uncontrolled diabetes or associated severe complications; * No active immunosuppressive diseases or high-dose immunosuppressive treatment; * No unstable or severe facial dermatological conditions; * No comorbidities seriously affecting quality of life or respiratory function (at the investigator's discretion). Exclusion Criteria * Non-English speaking subject * Subject under guardianship or legal protection, legally incompetent or with limited legal capacity * Subject unlikely to cooperate in the study and/or anticipated low cooperation by the investigator (particularly those with psychiatric disorders other than depression or cognitive disorders) * Pregnant or breastfeeding women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Carcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    9 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Caen

    NOT_YET_RECRUITING

    Caen, 14000, France

  • CHU Toulouse

    NOT_YET_RECRUITING

    Toulouse, 31400, France

  • Centre Antoine Lacassagne

    RECRUITING

    Nice, 06000, France

  • HNIA Toulon

    RECRUITING

    Toulon, 83000, France

  • Hopital Novo

    RECRUITING

    Pontoise, 95300, France

  • Hôpital Bichat (APHP)

    NOT_YET_RECRUITING

    Paris, 75018, France

  • Hôpital Lariboisière (AP-HP)

    NOT_YET_RECRUITING

    Paris, 75010, France

  • Institut Curie

    NOT_YET_RECRUITING

    Paris, 75005, France

  • Institut Gustave Roussy

    RECRUITING

    Villejuif, 94800, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.